TWO SIGMA INVESTMENTS, LP - ONCOMED PHARMACEUTICALS INC ownership

ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 55 filers reported holding ONCOMED PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of ONCOMED PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$11,000
-77.6%
14,738
-35.7%
0.00%
Q3 2018$49,000
-23.4%
22,938
-17.8%
0.00%
Q2 2018$64,000
-17.9%
27,894
+13.7%
0.00%
Q1 2018$78,000
-69.0%
24,537
-60.0%
0.00%
-100.0%
Q4 2017$252,000
+131.2%
61,365
+154.0%
0.00%
Q3 2017$109,000
-75.2%
24,160
-81.7%
0.00%
-100.0%
Q2 2017$439,000
+46.3%
131,867
+1196.4%
0.00%0.0%
Q4 2013$300,00010,1720.00%
Other shareholders
ONCOMED PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
BVF INC/IL 4,400,289$14,653,0002.28%
ADAMS STREET PARTNERS LLC 1,839,730$6,126,0001.44%
Iguana Healthcare Management, LLC 400,000$1,332,0000.75%
ELEMENT CAPITAL MANAGEMENT LLC 91,059$303,0000.06%
TURNER INVESTMENTS LLC 24,783$83,0000.06%
Birchview Capital, LP 28,689$96,0000.05%
Cannell & Co. 407,741$1,358,0000.05%
NJ State Employees Deferred Compensation Plan 48,000$160,0000.03%
DISCIPLINED GROWTH INVESTORS INC /MN 329,100$1,096,0000.02%
Burt Wealth Advisors 7,519$25,0000.02%
View complete list of ONCOMED PHARMACEUTICALS INC shareholders